Genetic diversity of Group A Streptococcus M protein: implications for typing and vaccine development (Q44417727)

2 December 2017

title

Genetic diversity of Group A Streptococcus M protein: implications for typing and vaccine development (English)

1 reference

2 December 2017

1 reference

Pierre R Smeesters

1

0 references

Patrick Mardulyn

series ordinal

2

object named as

Patrick Mardulyn

1 reference

2 December 2017

Anne Vergison

3

1 reference

2 December 2017

Raphaël Leplae

series ordinal

4

1 reference

2 December 2017

Laurence Van Melderen

series ordinal

5

1 reference

2 December 2017

language of work or name

English

0 references

publication date

25 September 2008

1 reference

2 December 2017

1 reference

2 December 2017

volume

26

1 reference

2 December 2017

issue

46

1 reference

2 December 2017

page(s)

5835-5842

1 reference

Molecular basis of group A streptococcal virulence

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

Group A streptococci among school-aged children: clinical characteristics and the carrier state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

Pathogenesis of group A streptococcal infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

Invasion mechanisms of Gram-positive pathogenic cocci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

Molecular typing of methicillin-resistant Staphylococcus aureus on the basis of protein A gene polymorphism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

Enhanced protection against Streptococcus pyogenes infection by intranasal vaccination with a dual antigen component M protein/SfbI lipid core peptide vaccine formulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

Bactericidal activity of M protein conserved region antibodies against group A streptococcal isolates from the Northern Thai population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

Multivalent group A streptococcal vaccine elicits bactericidal antibodies against variant M subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

Molecular mechanisms of adhesion, colonization, and invasion of group A streptococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

The global burden of group A streptococcal diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

Dynamic epidemiology of group A streptococcal serotypes associated with pharyngitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

Group A Streptococcal Pharyngitis Serotype Surveillance in North America, 2000–2002

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

Active bacterial core surveillance of the emerging infections program network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

High diversity of group A Streptococcal emm types in an Indian community: the need to tailor multivalent vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

M protein gene (emm type) analysis of group A beta-hemolytic streptococci from Ethiopia reveals unique patterns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

Genetically diverse group A streptococci from children in far-western Nepal share high genetic relatedness with isolates from other countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

High diversity of group A streptococcal emm types among healthy schoolchildren in Ethiopia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

Differences between Belgian and Brazilian group A Streptococcus epidemiologic landscape

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

Natural selection and evolution of streptococcal virulence genes involved in tissue-specific adaptations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

Population genetics and linkage analysis of loci within the FCT region of Streptococcus pyogenes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

Contrasting molecular epidemiology of group A streptococci causing tropical and nontropical infections of the skin and throat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

Multilocus sequence typing of Streptococcus pyogenes representing most known emm types and distinctions among subpopulation genetic structures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

Domains of group A streptococcal M protein that confer resistance to phagocytosis, opsonization and protection: implications for vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

Human pathogenic streptococcal proteomics and vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

Immunogenicity of a 26-valent group A streptococcal vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

Protection against group A streptococcus by immunization with J8-diphtheria toxoid: contribution of J8- and diphtheria toxoid-specific antibodies to protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

Progress towards developing a vaccine for group A streptococcus based on the M protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

M protein conserved region antibodies opsonise multiple strains of Streptococcus pyogenes with sequence variations in C-repeats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

Towards a vaccine against rheumatic fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

emm typing and validation of provisional M types for group A streptococci.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

Non-congruent relationships between variation in emm gene sequences and the population genetic structure of group A streptococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) Software Version 4.0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

New methods for inferring population dynamics from microbial sequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

Selection of conserved blocks from multiple alignments for their use in phylogenetic analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

Molecular typing of Streptococcus pyogenes from remote Aboriginal communities where rheumatic fever is common and pyoderma is the predominant streptococcal infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

Identification of a plasminogen-binding motif in PAM, a bacterial surface protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

emm and sof gene sequence variation in relation to serological typing of opacity-factor-positive group A streptococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

Extension of the Lancefield classification for group A streptococci by addition of 22 new M protein gene sequence types from clinical isolates: emm103 to emm124.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

Roles of the plasminogen activator streptokinase and the plasminogen-associated M protein in an experimental model for streptococcal impetigo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

Streptococcal M protein: molecular design and biological behavior.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

Protection against group A streptococcal infection by vaccination with self-adjuvanting lipid core M protein peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

Molecular characterisation of group A streptococci from invasive and non-invasive disease episodes in Belgium during 1993-1994

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

Size variation in group A streptococcal M protein is generated by homologous recombination between intragenic repeats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

RADAR: a web server for RNA data analysis and research.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

The REPRO server: finding protein internal sequence repeats through the Web.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

REPuter: fast computation of maximal repeats in complete genomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

M protein gene type distribution among group A streptococcal clinical isolates recovered in Mexico City, Mexico, from 1991 to 2000, and Durango, Mexico, from 1998 to 1999: overlap with type distribution within the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.037

10.1016/J.VACCINE.2008.08.037

7 January 2021

Identifiers

DOI

1 reference

2 December 2017

1 reference